Advertisement

Reactions Weekly

, Volume 1774, Issue 1, pp 67–67 | Cite as

Atezolizumab/durvalumab/tremelimumab

Myositis: 2 case reports
Case report
  • 24 Downloads

Reference

  1. Anquetil C, et al. Immune Checkpoint Inhibitor-Associated Myositis. Circulation 138: 743-745, No. 7, 14 Aug 2018. Available from: URL: http://doi.org/10.1161/CIRCULATIONAHA.118.035898 - France

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations